The current COVID-19 outbreak is a serious
disaster worldwide, including Bahrain. In this empirical paper, the ANN
approach was applied to analyze COVID-19 cases in Bahrain. This study is based
on daily new cases of COVID-19 in Bahrain for the period 1 January 2020 – 25
March 2021. The out-of-sample forecast covers the period 26 March 2021 – 31
July 2021. The residuals and forecast evaluation criteria (Error, MSE and MAE) of
the applied model indicate that the model is indeed stable in forecasting
COVID-19 cases in Bahrain. The results of the study suggest that daily COVID-19
cases in Bahrain are likely to remain significantly high over the out-of-sample
period. The government of Bahrain should ensure serious compliance to control
and preventive COVID-19 measures such as social distancing, quarantine,
isolation, face-mask wearing and so on, in line with WHO guidelines.
Country : Zimbabwe
1 Dr. Smartson. P. NYONI2 Mr. Thabani NYONI3 Mr. Tatenda. A. CHIHOHO
ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
Ackermann, M., et al.
(2020). Pulmonary Vascular Endothelialitis, Thrombosis and Angiogenesis in
COVID-19, New England Journal of Medicine,
pp: 1 – 11.
Ayinde, K., et al. (2020).
Modeling Nigerian COVID-19 Cases: A Comparative Analysis of Models and
Estimators, Chaos, Solitons and Fractals,
138 (2020): 1 – 17.
Barret, K., et al. (2020).
Estimation of COVID-19-induced Depletion of Hospital Resources in Ontario,
Canada, CMAJ, pp: 1 – 7.
Chimmula, V. K. R., & Zhang, L. (2020). Time Series Forecasting of
COVID-19 Transmission in Canada Using LSTM Networks, Chaos, Solitons and Fractals, 135 (2020): 1 – 6.
Fisman, D. N., et al.
(2020). Derivation and Validation of Clinical Prediction Rule for COVID-19
Mortality in Ontario, Canada, medRxiv,
pp: 1 – 50.
Nahum, J., et al. (2020).
Venous Thrombosis Among Critically ill Patients With Coronavirus Disease 2019
(COVID-19), JAMA, 3 (5): 1 – 7.
Wang, D., et al. (2020).
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-infected Pneumonia in Wuhan, China, JAMA, pp: 1 – 9.
Zhang, C., et al. (2020).
Cytokine Release Syndrome in Severe COVID-19: Interleukin-6 Receptor Antagonist
Tocilizumab may be the Key to Reduce Mortality, International Journal of Antimicrobic Agents, 55 (5): 1 – 16.
